The Global Narcolepsy Therapeutics Market is Predict to reach $5 Billion by 2028, at a CAGR of 10.5%

Published Date: 23-Sep-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Narcolepsy Therapeutics Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Narcolepsy Therapeutics Market size is expected to reach $5 billion by 2028, rising at a market growth of 10.5% CAGR during the forecast period.

The Narcolepsy without Cataplexy segment is showcasing a CAGR of 10.6% during (2022 - 2028). It is due to the rise in public knowledge brought on by awareness initiatives run by several networks, including the U.S. Narcolepsy Network and the Europe Narcolepsy Network. EDS is frequently the initial clinically noticeable sign. The most frequent cause of EDS in the United States, according to the National Institute of Neurological Disorders and Stroke, is sleep deprivation.

The Sodium Oxybate segment acquired maximum revenue share in the Global Narcolepsy Therapeutics Market by Product in 2021 thereby, achieving a market value of $2.1 billion by 2028. Due to the expensive price of this drug, the existence of favorable reimbursement policies, and the expanding levels of knowledge regarding diagnosis & related treatments. The FDA-approved medicine in this class, Xyrem, has a high prescription rate because it is specifically intended for use in treating cataplexy and its accompanying EDS.

The Europe market dominated the Global Narcolepsy Therapeutics Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.6 billion by 2028. The North America market is exhibiting a CAGR of 9.8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 11.4% during (2022 - 2028).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.

Global Narcolepsy Therapeutics Market Segmentation

By Type

  • Narcolepsy with Cataplexy
  • Narcolepsy Without Cataplexy
  • Secondary Narcolepsy

By Product

  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Narcolepsy Therapeutics Market size & Opportunities 2022-2028

Europe Narcolepsy Therapeutics Market & Growth Forecast 2022-2028

Asia Pacific Narcolepsy Therapeutics Market Share & Industry Outlook to 2028

LAMEA Narcolepsy Therapeutics Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.